We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · September 14, 2021

Projecting the Prevalence and Costs of Metastatic Breast Cancer From 2015 Through 2030

JNCI Cancer Spectrum

 

Additional Info

Disclosure statements are available on the authors' profiles:

JNCI Cancer Spectrum
Projecting the Prevalence and Costs of Metastatic Breast Cancer From 2015 Through 2030
JNCI Cancer Spectr 2021 Aug 01;5(4)pkab063, A Gogate, SB Wheeler, KE Reeder-Hayes, DU Ekwueme, TL Fairley, S Drier, JG Trogdon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading